Continuum Advisory’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,339
| Closed | -$20.6K | – | 1450 |
|
|
2025
Q1 | $20.6K | Buy |
1,339
+58
| +5% | +$891 | ﹤0.01% | 853 |
|
|
2024
Q4 | $28.2K | Buy |
1,281
+106
| +9% | +$2.34K | ﹤0.01% | 775 |
|
|
2024
Q3 | $19.7K | Buy |
1,175
+847
| +258% | +$14.2K | ﹤0.01% | 850 |
|
|
2024
Q2 | $5.33K | Buy |
328
+83
| +34% | +$1.35K | ﹤0.01% | 1069 |
|
|
2024
Q1 | $3.92K | Buy |
+245
| New | +$3.92K | ﹤0.01% | 1118 |
|